Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goh Ohji

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Infection|October 13, 2019
Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporinsAtsushi Uda, Takeshi Kimura, Sho Nishimura, et al.
Journal of Pharmaceutical Health Care and Sciences|September 3, 2024
Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational studyTakeshi Tomida, Takeshi Kimura, Kazuhiro Yamamoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 19, 2025
Treatment satisfaction and needs among people living with HIV who have incomplete viral load suppression in Japan: A multicenter, cross-sectional, observational studyTakeshi Kimura, Shinichi Hikasa, Masashi Ishihara, et al.
Heart Rhythm|April 9, 2025
Identification of causative organisms using enrichment cultures for cardiac implantable electronic device infectionsYusuke Nakanishi, Mitsuru Takami, Goh Ohji, et al.
Vaccines|June 24, 2022
Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose VaccinationYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 29, 2022
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancerYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
British Journal of Haematology|June 23, 2023
Response to mRNA SARS-CoV-2 vaccination evaluated by B-cell receptor repertoire after tixagevimab/cilgavimab administrationYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
Vaccines|February 26, 2022
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell TransplantationMarika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Ejhaem|August 19, 2024
Analysis of B-cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccinesYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
Infection|November 15, 2017
Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedbackTakeshi Kimura, Atsushi Uda, Tomoyuki Sakaue, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Infection|October 13, 2019
Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporinsAtsushi Uda, Takeshi Kimura, Sho Nishimura, et al.
Journal of Pharmaceutical Health Care and Sciences|September 3, 2024
Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational studyTakeshi Tomida, Takeshi Kimura, Kazuhiro Yamamoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 19, 2025
Treatment satisfaction and needs among people living with HIV who have incomplete viral load suppression in Japan: A multicenter, cross-sectional, observational studyTakeshi Kimura, Shinichi Hikasa, Masashi Ishihara, et al.
Heart Rhythm|April 9, 2025
Identification of causative organisms using enrichment cultures for cardiac implantable electronic device infectionsYusuke Nakanishi, Mitsuru Takami, Goh Ohji, et al.
Vaccines|June 24, 2022
Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose VaccinationYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 29, 2022
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancerYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
British Journal of Haematology|June 23, 2023
Response to mRNA SARS-CoV-2 vaccination evaluated by B-cell receptor repertoire after tixagevimab/cilgavimab administrationYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
Vaccines|February 26, 2022
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell TransplantationMarika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Ejhaem|August 19, 2024
Analysis of B-cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccinesYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
Infection|November 15, 2017
Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedbackTakeshi Kimura, Atsushi Uda, Tomoyuki Sakaue, et al.
Pageof 6